BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

The Forbes Healthcare Summit: The Final Agenda

This article is more than 6 years old.

Forbes

We're only nine days away. Starting at 5 o'clock in the evening on November 29, Forbes will host our annual Healthcare Summit, a 24-hour meeting (time off for sleep) of the top executives from the pharmaceutical, insurance and hospital sectors. Among the highlights this year: deep, multi-part look at the opioid crisis; a group therapy session between top payers and providers, and a set of radical ideas for transforming healthcare. And that's before a deep look at the state of the drug business featuring the chief executives of many of the industry's biggest companies. There's still some space available, and you can ask for an invite by emailing healthcare@forbes.com or by clicking on this link. I hope to see you there!

The Forbes Healthcare Summit 2017: Healing Medicine’s Pain Points

November 29, 2017

4:30pm             Registration

5:00pm             Welcome

  • Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

5:05pm Spotlight: Stopping Cancer With Cells: The CEO of the Leukemia and Lymphoma Society talks with a patient whose life was saved by cutting-edge cancer therapy.

  • Louis J. DeGennaro, PhD, President & Chief Executive Officer, The Leukemia & Lymphoma Society  (LLS)
  • Patient Advocates: Austin, Kimberly & Jeffrey Schuetz

5:15pm Aiming For The Next Breakthrough

Novartis just revolutionized cancer treatment, again, with cells that hunt down and kill tumors. Incoming chief executive Vas Narasimhan talks about this historic first and what’s coming next.

  • Vas Narasimhan, Global Head of Drug Development & Chief Medical Officer, Novartis
  •  Interviewer: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

5:35pm Spotlight: Using Big Data To Find The Best Doctors featuring Owen Tripp, Co-Founder & Chief Executive Officer, Grand Rounds

5:40pm The Billionaire Behind The World’s Largest Drugstore Chain

Stefano Pessina’s creation of the Walgreens Boots Alliance is a bet on scale and volume. What does he foresee for the future of healthcare?

  • Stefano Pessina, Executive Vice Chairman & Chief Executive Officer, Walgreens Boots Alliance
  • Interviewer: Moira Forbes, Executive Vice President, Forbes Media

6:00pm Cocktail Reception

7:00pm  Salon Dinners (by special invitation only)

Forbes

November 30, 2017

7:00am             Breakfast 

8:00am             Welcome

Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

8:10am             Opening Remarks

Steve Forbes, Chairman & Editor-in-Chief, Forbes Media

8:20am Five Fixes for Healthcare

It’s time for some big ideas. We asked these visionaries what they would do to improve U.S. healthcare if they had a magic wand. They’ll present their answers -- and then debate their solutions.

  • The Government Should Buy Gilead Sciences
    Peter B. Bach, MD, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Tax Pharma To Pay For NIH
    Laurie Glimcher, MD, Chief Executive Officer, Dana-Farber Cancer Institute
  • How Smartphones Will Transform Healthcare
    Diane P. Holder, President & Chief Executive Officer, UPMC Health Plan
  • Healthcare Is About Buildings & Food
    Barry H. Ostrowsky, President & Chief Executive Officer, RWJBarnabas Health
  • Make Scientists The Real Celebrities
    George Yancopoulos, President & Chief Scientific Officer, Regeneron
  • Moderator: Michael Noer, Executive Editor, Forbes Magazine

9:00am The Plan For Medicare And Medicaid

Seema Verma was put in charge of government’s health insurance offerings based on her experience in Indiana, where she helped create and implement the Nation’s first consumer-directed Medicaid program. Here, she will lay out her agenda.

  • Seema Verma, Administrator, Centers for Medicare and Medicaid Services
  • Interviewer: Avik Roy, President, The Foundation for Research on Equal Opportunity; Opinion Editor, Forbes Media

9:20am What The Heck Does ‘Value’ Mean?

Everyone is talking about delivering value. But nobody seems to quite agree what it means. We get payors and providers to the table to hammer out a definition.

  • Patrick Conway, MD, MSc, President & Chief Executive Officer-Elect, Blue Cross and Blue Shield of North Carolina
  • Michael Dowling, President & Chief Executive Officer, Northwell Health
  • Steve Nelson, Chief Executive Officer, UnitedHealthcare
  • Richard Rothman, MD, PhD, Founder, The Rothman Institute, Thomas Jefferson University Hospital
  • Moderator: Steve Forbes, Chairman & Editor-in-Chief, Forbes Media

9:55am Spotlight: Treating My Own Disease

  • David Fajgenbaum, MD, MBA, MSc, Assistant Professor of Medicine, University of Pennsylvania; Co-Founder & Executive Director, Castleman Disease Collaborative Network; Forbes 30 Under 30 Alumnus.

10:00am Dissecting The Drug Dollar

What happens to drugs before you buy them, and what does it cost? Companies from across the system will break down the pharmaceutical supply chain.

  • John Maraganore, Chief Executive Officer, Alnylam
  • Stephen Ubl, President & Chief Executive Officer, Pharmaceutical Research & Manufacturers of America
  • Tim Wentworth, President & Chief Executive Officer, Express Scripts
  • Moderator: Avik Roy, President, The Foundation for Research on Equal Opportunity; Opinion Editor, Forbes Media

10:35am Morning Break 

11:05am The Opioid Epidemic

The widespread availability -- and heavy marketing -- of sustained release opioid pills created a national crisis. Last year, 50,000 Americans died of opioid overdoses. How do we close this Pandora’s box?

Part I: From High School Dean To Heroin Addict To Licensed Professional Counselor 

  • Nicholas deSpoelberch, Licensed Professional Counselor in Recovery

Part II:  A Personal History Of Addiction

  • Nora D. Volkow, MD, Director, National Institute on Drug Abuse
  • Interviewer: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

Part III: Solutions

  • Troyen A. Brennan, MD, MPH, Executive Vice President & Chief Medical Officer, CVS Health
  • Thomas R. Frieden, MD, MPH, Former Director, Centers for Disease Control and Prevention;
  • President & Chief Executive Officer, Resolve to Save Lives
  • Patrice A. Harris, MD, MA, Immediate Past Chair, Board of Trustees, American Medical Association
  • Andrew Kolodny, MD, Co-Director of The Opioid Policy Research Collaborative, The Heller School for Social Policy and Management
  • Nora D. Volkow, MD, Director, National Institute on Drug Abuse
  • Moderator: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

11:55am Spotlight: Transplanting Pig Organs Into People

  • Luhan Yang, PhD, Co-Founder & Chief Scientific Officer, eGenesis; Forbes 30 Under 30 Alum

12:00pm Transformations: An Interview With Martine Rothblatt

Martine Rothblatt helped created satellite radio. She founded a biotech company to help sick kids who suffered from the same illness as her child. What’s next? Pig-to-human organ transplants. Robotics. Regenerative Medicine. And extending the human lifespan towards...forever.

  • Martine Rothblatt, Chairman & Chief Executive Officer, United Therapeutics
  • Interviewer: Moira Forbes, Executive Vice President, Forbes Media

12:15pm Lunch

Forbes

1:30pm Return To Order

  • Steve Forbes, Chairman & Editor-in-Chief, Forbes Media

1:35pm Hacking Your Health

Driven by big companies with big-time health spending, Silicon Valley aims to use machine learning and other technologies to transform public health.

  • Your Genes: Tony Wang, Chief Operating Officer, Color
  • Your Pancreas: Sami Inkinen, Founder & Chief Executive Officer, Virta Health
  • Aging: Seth Sternberg, Co-Founder & Chief Executive Officer, Honor
  • Your Bill: Rajaie Batniji, Co-Founder & Chief Health Officer, Collective Health
  • Moderator: Josh Wolfe, Co-Founder & Managing Partner, Lux Capital

2:05pm            Machine Medicine

Artificial intelligence. Machine learning. Case studies of using electronic data the right way to make discoveries and guide practice. A look at how computers will change healthcare.

  • Carsten Brunn, Head of Pharmaceuticals, Americas Region, Bayer
  • Jonathan Bush, Co-Founder and Chief Executive Officer, athenahealth
  • August Calhoun, PhD, Senior Vice President, North America Services, Siemens Healthineers
  • Colin Hill, Co-Founder, Chairman & Chief Executive Officer, GNS Healthcare
  • Moderator: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

2:40pm Afternoon Break

3:15pm Spotlight: The Promise Of Gene Editing

The CEO of the Leukemia and Lymphoma Society talks with a patient whose life was saved by cutting-edge cancer therapy.

  • Louis J. DeGennaro, PhD, President & Chief Executive Officer, The Leukemia And LymphomaSociety (LLS)
  • Patient Advocate: Emily Dumler

Forbes

3:20pm Gene Therapy Comes Of Age

Until now, the idea of editing the genes that cause disease was just a dream. But data emerging this year means gene therapy is finally ready for prime time. The biggest question now? How to manage the financial cost.

  • Arie Belldegrun, MD, FACS, Founder, Kite
  • Nick Leschly, chief executive officer, bluebird bio
  • Jeffrey D. Marrazzo, Co-Founder & Chief Executive Officer, Spark Therapeutics
  • Moderator: Meg Tirrell, Reporter, CNBC

3:55pm Spotlight: An Ultrasound in Your Pocket

  • Nevada Sanchez, Co-Founder, Butterfly Network; Forbes 30 Under 30 Alumnus

4:00pm The Pharma All-Stars

The drug industry’s ability to innovate -- and its ability to charge high prices -- are at the center of the healthcare debate, whether they like it or not. In this signature panel, we’ll assemble some of the industry’s top CEOs.

  • Kenneth C. Frazier, Chairman of the Board & Chief Executive Officer, Merck & Co., Inc.
  • Ian Read, Chairman & Chief Executive Officer, Pfizer
  • David A. Ricks, Chairman & Chief Executive Officer, Eli Lilly & Company
  • Brenton L. Saunders, Chairman, President & Chief Executive Officer, Allergan
  • Leonard Schleifer, MD, PhD, President & Chief Executive Officer, Regeneron
  • Moderator: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

4:45pm Closing Remarks

  • Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media